CARE Ratings Hits 52-Week High, Outperforms Sector with Strong Growth
CARE Ratings, a leading smallcap company in the ratings industry, has reached a 52-week high with its stock price hitting Rs.1535 on November 5th, 2024. The company has outperformed the sector by 2.67% and its moving averages are trading higher, indicating a strong upward trend. With a 1-year performance of 79.83%, CARE Ratings has established itself as a reliable and successful player in the market.
CARE Ratings, a leading smallcap company in the ratings industry, has recently hit a 52-week high with its stock price reaching Rs.1535 on November 5th, 2024. This positive trend has been noticed by market experts, with MarketsMOJO giving a 'Buy' call for the stock.
The company's performance today has also been impressive, outperforming the sector by 2.67%. This is reflected in its moving averages, with CARE Ratings trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This indicates a strong upward trend in the stock's price.
In comparison to the overall market performance, CARE Ratings has shown exceptional growth with a 1-year performance of 79.83%, while the Sensex has only grown by 22.33%. This showcases the company's strong position in the ratings industry and its ability to deliver consistent returns to its investors.
CARE Ratings has established itself as a reliable and trustworthy player in the smallcap market, providing accurate and unbiased ratings for various industries. With its consistent growth and positive outlook, the company is poised for further success in the future. Investors can look forward to a promising future with CARE Ratings as a part of their portfolio.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
